The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.
Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
1 | 3 | 6 | 7 |
Growth
|
91 | 79 | 97 | 99 |
Safety
|
27 | 46 | 58 | 24 |
Sentiment
|
23 | 55 | 63 | 32 |
|
10 | 34 | 67 | 21 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Analyst Opinions
|
47 | 53 | 59 | 100 |
Opinions Change
|
22 | 43 | 59 | 50 |
Pro Holdings
|
n/a | 74 | 39 | 1 |
Market Pulse
|
52 | 66 | 74 | 33 |
Sentiment
|
23 | 55 | 63 | 32 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
1 | 3 | 6 | 7 |
Growth
|
91 | 79 | 97 | 99 |
|
27 | 46 | 58 | 24 |
Combined
|
18 | 26 | 65 | 32 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Price vs. Sales (P/S)
|
5 | 7 | 12 | 22 |
Price vs. Earnings (P/E)
|
4 | 3 | 7 | 17 |
Price vs. Book (P/B)
|
11 | 12 | 24 | 26 |
Dividend Yield
|
18 | 14 | 12 | 1 |
Value
|
1 | 3 | 6 | 7 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Revenue Growth
|
94 | 94 | 89 | 53 |
Profit Growth
|
90 | 65 | 44 | 100 |
Capital Growth
|
28 | 27 | 95 | 91 |
Stock Returns
|
91 | 81 | 89 | 100 |
Growth
|
91 | 79 | 97 | 99 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Leverage
|
41 | 52 | 68 | 60 |
Refinancing
|
16 | 11 | 23 | 17 |
Liquidity
|
50 | 72 | 61 | 16 |
|
27 | 46 | 58 | 24 |
Discover high‑ranked alternatives to Max Healthcare Institute and broaden your portfolio horizons.
The Obermatt Advantage
Choose the Obermatt subscription that best fits your needs.